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ABSTRACT 
International Journal of Exercise Science 14(2): 222-229, 2021. The purpose of this study was to 
investigate the influence of acetic acid (apple cider vinegar; ACV) supplementation on resting and exercise energy 
expenditure and substrate utilization. Using a randomized, double blind, crossover design, 16 healthy subjects were 
supplemented for 4 d with either ACV (30-ml/d) mixed in 1 L of a non-nutritive lemon-flavored drink or a placebo 
(PLA). They were then assessed via indirect calorimetry for resting energy expenditure (REE) and substrate 
utilization. This was immediately followed by the assessment of steady state cycling exercise energy expenditure 
at 40 W (EEE-40) and 80 W (EEE-80) and substrate utilization. Results: Neither REE nor resting substrate utilization 
were significantly different between groups (p ≥ .05). During cycling exercise at both 40W and 80W, there were no 
significant differences observed between groups for energy expenditure (EEE-40: ACV 4.13 ± 0.79, PLA 4.37 ± 0.61 
kcal/min; EEE-80: ACV 6.09 ± 0.87, PLA 6.26 ± 0.72 kcal/min) or substrate utilization (40W carbohydrate: ACV 0.72 
± 0.19, PLA 0.76 ± 0.16; fat: ACV 0.15 ± 0.07, PLA 0.16 ± 0.06 g/min), (80W carbohydrate: ACV 1.28 ± 0.32, PLA 1.34 
± 0.35; fat: ACV 0.14 ± 0.10, PLA 0.14 ± 0.10 g/min) (p ≥ .05). Conclusions: Recent findings suggest that chronic 
acetic acid supplementation is associated with significant reductions in body weight and body fat; however, the 
findings of the present study suggest that a semi-acute (4 d) acetic acid supplementation does not impact resting or 




Vinegar’s origin is largely shrouded in mystery. Legend states that a courtier in Babylonia (5,000 
BC) “discovered” wine, from forgotten grape juice, leading to the eventual discovery of both 
vinegar and its food preserving capabilities (7). Ancient civilizations used vinegar for a variety 
of purposes, with Hippocrates using it to treat wounds, fever, and sores (2). Early U.S. 
practitioners used it to treat poison ivy, croup, stomachache, high fever, and edema (2). 
 
With the increasing popularity of at-home medicine, researchers have recently begun to 
investigate some of the purported health benefits of vinegar (4). Most notably, improved 
cardiovascular function (12, 18) and glycemic control (1, 8, 13). Additionally, vinegar has been 
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shown to increase fatty acid oxidation, interrupt lipogenesis, increase energy expenditure, and 
reduce body mass and fat mass (10, 6, 21). 
 
Investigation into vinegar’s role in weight loss has been primarily limited to animal models (6, 
10, 21) and the mechanisms by which it stimulates weight loss are still unclear. Proposed 
mechanisms include an interruption of glucose stimulated lipogenesis (21), an increase in 
thermogenesis and fatty acid oxidation (10), and an increase in energy expenditure and 
alterations in substrate utilization (6). In the only two reported human trials, vinegar was shown 
to reduce both body mass and fat mass (9, 11). While the mechanisms by which vinegar may 
stimulate weight loss in humans are unclear, two notions have been posited. 1) it stimulates an 
increase in satiety (3, 15), and 2) it increases energy expenditure and substrate oxidation (6).  
 
While there are several animal studies suggesting a positive effect of vinegar supplementation 
on energy balance and weight management (6, 10, 21), there is a paucity of investigations of its 
effects in humans (11). Therefore, the purpose of this study was to investigate the effect of semi-
acute vinegar supplementation on resting and exercise energy expenditure, as well as substrate 
utilization at rest and during steady state exercise. It was hypothesized that a 3-day 
administration of vinegar would stimulate changes in resting and exercise metabolism and 




This research was approved by the Institutional Review Board for the use of Human Subjects 
in Research (IRB-03379-2016) and was carried out fully in accordance to the ethical standards 
of the International Journal of Exercise Science (14). Inclusion criteria were non-smoking 
individuals over the age of 18, free of any metabolic altering medical conditions, and not 
consuming any nutritional/mineral supplements during the previous 30-d. Participants were 
required to maintain their normal physical activity levels through the duration of the study. 
For each laboratory testing session, subjects were requested to be at least 4-h post prandial, 
having refrained from exercise within the previous 12-h, and also having abstained from 
caffeine and alcohol for at least 24-h prior.  
 
Each participant arrived in the laboratory on three separate occasions, with a minimum of 2-d 
between visits. The first visit was a familiarization trial. The second and third visits were 
experimental trials, one being a treatment trial and the other being a placebo trial. These 




Upon arrival in the laboratory, subjects completed an informed consent, Physical Activity 
Readiness Questionnaire (19) and a health history questionnaire, and were then assessed for 
measures of body mass, height, and body composition (Discovery DXA System, Marlborough, 
MA). They then underwent a familiarization trial during which resting energy expenditure 
(REE) was estimated via open-circuit indirect calorimetry (Vmax Encore Metabolic Cart; Yorba 
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Linda, CA). Flow volume and gas calibrations were performed prior to each testing session 
according to the manufacturer’s instructions. Subjects were asked to assume a supine position 
and a Plexiglas ventilated hood was placed over their head. Expired gases were assessed for 30-
min during which the flow rate was monitored to insure a FECO2 between 0.75-0.85%. The REE 
was determined from 5-min of steady state respiratory gas measurements assessed during 
minutes 20-30.  
 
Upon completion of the REE assessment, the metabolic cart was immediately recalibrated to 
facilitate exercise testing and the subject was fitted with a facemask and mass flow sensor. The 
subject then performed 20-min of continuous exercise on a cycle ergometer (Monark 874 E, 
Vansbro, Sweden) with the first 10-min performed at 40-Watts and the last 10-min performed at 
80-Watts. Heart rate was monitored via telemetry (Polar electro Inc., Lake success, NY) and 
recorded during the final 2-min of each workload. Expired gas volumes and fractional 
concentrations of O2 and CO2 were analyzed and used in the assessment of energy expenditure 
and substrate utilization. Energy expenditure was calculated as [3.94(VO2) + 1.1(VCO2)] (20) 
with resting data expressed as kcal/d and exercise data expressed as kcal/min. Substrate 
oxidation rates were calculated for fat as [1.695(VO2) – 1.701(VCO2)] and carbohydrate as 
[4.585(VCO2) – 3.226(VO2)] with resting data expressed as g/d and exercise data expressed as 
g/min (16). 
 
Subsequent to completion of the familiarization trial, treatment and placebo trials were 
administered in a randomized, double blind fashion and the solutions were prepared by an 
individual not involved in data collection or having any participant interaction. For each of the 
trials, subjects were provided six drink bottles, each containing 500 ml of either the treatment or 
placebo solution. Subjects were instructed to drink the contents of one bottle in the morning and 
one bottle in the evening for three consecutive days. On the fourth day, they arrived in the 
laboratory and were instructed to consume an additional 500 ml of the respective solution. 1-h 
post consumption they were then assessed for REE and exercise energy expenditure (EEE) in 
the same fashion as described in the familiarization trial. Following a minimum of 2-d, subjects 
then completed the alternate trial condition. 
 
The treatment and placebo solutions both consisted of a flavored, low-calorie drink mix (Crystal 
Light Lemonade, Kraft Foods, Chicago, Illinois). This was mixed at 150% of the manufacturer’s 
recommended concentration to provide a strong lemonade flavor and to increase tartness and 
sweetness in an attempt to disguise the vinegar taste. The treatment solution also contained an 
addition of 30-ml of apple cider vinegar (Double Shot - Apple Cider Vinegar with the Mother; 
Vermont Village, Village Cannery of Vermont, New Hampshire) in each liter of solution. While 
not directly assessed, informal debriefing of several subjects indicated that the drinks were 
indistinguishable from one another. 
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Statistical Analysis 
A 3 x 9 Factorial Analysis of Variance was used to assess for differences between the three trials 
(familiarization, treatment, placebo) for REE (kcal/day), resting substrate utilization (g 
carbohydrates (CHO)/day and g fat/day), EEE (kcal/min) and substrate utilization (g 
CHO/min and g fat/min) at both 40-Watts and 80-Watts. All data were reported as mean ± SD 




Demographics (Table 1). A total of 21 participants volunteered to participate in the study and met 
the inclusion criteria; however, three were excluded due to noncompliance with 
supplementation or attendance, and there was corruption of the data for two additional subjects, 
leaving a final participant pool of n = 16 (5 males, 11 females). There were no adverse events 
reported during the course of the study. 
 
Table 1. Subject demographics. Values are expressed as mean ± SD. 
Body weight (kg) 72.2 ± 12.2 
Height (cm) 168.7 ± 10.8 
Age (yr) 22 ± 2 
Body fat (%) 23.6 ± 5.5 
 
Resting energy expenditure (REE) and substrate utilization (Table 2). REE was not significantly 
different between groups (p ≥ .05). Effect sizes calculated as Cohens d (placebo vs. treatment) 
REE: .06, Fat: .08, Carbohydrate: .15. There were also no significant differences in resting 
substrate utilization between treatments. 
 
Table 2. Resting energy expenditure and substrate utilization. Values are expressed as mean ± SD. 
 Familiarization Placebo Vinegar 
Resting energy expenditure (kcal/d) 1629 ± 209 1654 ± 235 1669 ± 264 
Substrate utilization (g/d)    
Fat 114.8 ± 44.1 121.5 ± 36.8 118.4 ± 36.7 
Carbohydrate 155.0 ± 147.7 135.2 ± 75.7 146.4 ± 65.8 
 
Exercise Energy Expenditure (EEE) and substrate utilization (Figure 1). EEE was not significantly 
different between groups at cycling power outputs of either 40W or 80W (Table 3). Effect sizes 
calculated as Cohens d (placebo vs. treatment) 40W: .34, 80W: .21. Likewise, there were no 
significant between group differences in either fat or carbohydrate utilization at cycling power 
outputs of 40W or 80W.  
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Figure 1. Substrate utilization for Familiarization, Placebo and Treatments trials at cycling power outputs of 40-
Watts and 80-Watts, respectively. There were no significant differences noted between trials for carbohydrate or 
fat utilization at either cycling intensity (p ≥ .05). 
 
The cycling power outputs employed in this study, 40-Watts and 80-Watts, were chosen to 
elicit light and moderate intensity efforts, respectively. The cycling power output of 40-Watts 
elicited a heart rate of 105 ± 15 b/min which equated to 53 ± 7% of age predicted maximal 
heart rate (APMHR) (220-age). The cycling power output of 80-Watts elicited a heart rate of 




The administration of acetic acid, the main component of vinegar, to mice was reported by 
Kondo et al. (10) to suppress fat deposition and weight gain, while at the same time maintaining 
skeletal muscle mass. Hattori et al. (6) supported these findings when they reported that acetic 
acid administration significantly increased energy expenditure and suppressed fat 
accumulation. While these reports were derived from animal work, it immediately drew interest 
in the potential use of vinegar in weight management in humans. Two human studies furthered 
this interest when it was reported that vinegar supplementation was associated with significant 
loss of both body mass and fat mass (9, 11). In light of these findings, the purpose of the present 
study was to investigate if semi-acute vinegar supplementation would have any impact on REE 
or steady state EEE, as well as substrate utilization both at rest and during exercise. In contrast 
with these previous studies, our findings indicate that vinegar supplementation does not 
increase energy expenditure or substrate utilization at rest or during light or moderate intensity 
exercise.  
 
There are several factors, at least in part, that may provide insight into the contrasting findings 
reported in the present study. The first factor to be considered is the choice of an acute or chronic 
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gastric tube, of a 1.5% acetic acid solution to laboratory mice. This protocol demonstrated an 
increase in energy expenditure and fat oxidation 1 h after administration. Kondo et al. (11) chose 
a chronic protocol consisting of 12 weeks of either a low dose (15 ml/d) or a high dose (30 ml/d) 
vinegar consumption delivered in a 0.5 L of solution. Their findings revealed a progressive and 
significant reduction in body mass, BMI, and body fat mass after 4-, 8-, and 12-weeks, 
respectively. Interestingly, four weeks after discontinuing the vinegar administration, all of 
these measures had returned to the pre-treatment values. Khezri et al. (9) also chose to 
investigate a chronic vinegar supplementation using the same quantity as Kondo et al. (11); 
however, in this instance, rather than subjects consuming the vinegar diluted in solution, 
subjects consumed 15-ml of vinegar with a salad at both lunch and dinner (30-ml daily). Similar 
to the findings of Kondo et al. (11), the vinegar treatment was associated with significant changes 
in body mass, BMI, and visceral adiposity.  
 
The experimental design of the present study was a compromise of these previous studies in 
that a “semi-acute” administration was chosen. In this, each day the subjects consumed the same 
total volume of vinegar (30 ml/d) as Kherzi et al. (9) and Kondo et al. (11) with 15-ml of vinegar 
consumed in 0.5-L of solution two times per day. Subjects arrived in the laboratory and 
consumed a final 15-ml of vinegar in 0.5-L of solution. 1-h later they underwent assessment for 
indirect calorimetry which is similar in timing to the administration and assessment chosen by 
Hattori et al (6). Despite our experimental protocol attempting to maximize the variables 
previously associated with significant findings, our results did not support these earlier studies.  
 
The mechanism by which acetic acid/vinegar impacts body mass and composition has yet to be 
fully elucidated; however, there are generally two schools of thought: 1) It enhances energy 
expenditure, suppresses carbohydrate utilization, and enhances fat oxidation (10, 21), or 2) It 
reduces hunger and hence, energy intake (2, 9, 15, 17). This study was designed to specifically 
investigate vinegar’s influence on energy expenditure and substrate utilization. While animal 
work has demonstrated vinegar to significantly impact these parameters (6, 10, 20), the fact that 
no statistically significant differences were revealed in our study suggests that, at least in 
humans, if vinegar is to have an impact on weight management and body composition, the 
research focus needs to be directed toward chronic supplementation and its effect on satiety and 
energy intake. 
 
This study carried several limitations. First, there was no direct assessment of the effectiveness 
of the treatment masking protocol. However, during informal debriefing of subjects there were 
no reports of being able to distinguish between the treatment or placebo. Second, no direct 
assessments were taken of reported side effects during the treatment or placebo protocols. Past 
literature has reported the unpalatable nature of vinegar as a possible explanation for weight 
loss (3). However, considering some groups have controlled for energy intake, this notion is 
unlikely (11). 
 
To the author’s knowledge this is the first study to investigate the effect of vinegar 
supplementation on resting and exercise energy expenditure and substrate utilization in 
humans. While previous vinegar supplementation studies have demonstrated body and fat 
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mass loss, the present findings suggest this is not due to acute changes in metabolic rate or 
substrate utilization. Future vinegar supplementation research should be directed toward 
investigating the impact of chronic supplementation, specifically its effects on energy 




1. Brighenti F, Castellani G, Benini L, Casiraghi M C, Leopardi E, Crovetti, R Testolin G. Effect of neutralized and 
native vinegar on blood glucose and acetate responses to a mixed meal in healthy subjects. European Journal of 
Clinical Nutrition, 49(4): 242–247, 1995. 
2. Budak NH, Aykin E, Seydim AC, Greene AK, Guzel-Seydim ZB. Functional properties of vinegar. Journal of 
Food Science 79(5): R757-764, 2014. https://doi.org/10.1111/1750-3841.12434 
3. Darzi J, Frost GS, Montaser R, Yap J, Robertson MD. Influence of the tolerability of vinegar as an oral source of 
short-chain fatty acids on appetite control and food intake. International Journal of Obesity. 38(5): 675–681, 2014. 
https://doi.org/10.1038/ijo.2013.157 
4. Ernst E. Rise in popularity of complementary and alternative medicine: Reasons and consequences for 
vaccination. Vaccine, 20: S90–S93, 2001. https://doi.org/10.1016/S0264-410X(01)00290-0 
5. Fushimi T, Sato Y. Effect of acetic acid feeding on the circadian changes in glycogen and metabolites of glucose 
and lipid in liver and skeletal muscle of rats. Br. J. Nutr. 94: 714–719, 2005. 
6. Hattori M, Kondo T, Kishi M, Yamagami, K. A single oral administration of acetic acid increased energy 
expenditure in C57BL/6J mice. Bioscience, Biotechnology, and Biochemistry, 74(10): 2158–2159, 2010. 
https://doi.org/10.1271/bbb.100486 
7. Johnston C. Medicinal Uses of Vinegar. Complementary and Alternative Therapies and the Aging Population, 
433–443, 2009. https://doi.org/10.1016/B978-0-12-374228-5.00022-6 
8. Johnston CS, Steplewska I, Long CA, Harris LN, Ryals RH. Examination of the antiglycemic properties of 
vinegar in healthy adults. Annals of Nutrition & Metabolism, 56(1): 74–79, 2010. 
https://doi.org/10.1159/000272133 
9. Khezri SS, Saidpour A, Hosseinzadeh N, Amiri Z. Beneficial effects of Apple Cider Vinegar on weight 
management, Visceral Adiposity Index and lipid profile in overweight or obese subjects receiving restricted calorie 
diet: A randomized clinical trial. Journal of Functional Foods, 43: 95–102, 2018.  
https://doi.org/10.1016/j.jff.2018.02.003 
10. Kondo T, Kishi M, Fushimi T, Kaga T. Acetic acid upregulates the expression of genes for fatty acid oxidation 
enzymes in liver to suppress body fat accumulation. Journal of Agricultural and Food Chemistry, 57(13): 5982–
5986, 2009. https://doi.org/10.1021/jf900470c 
11. Kondo T, Kishi M, Fushimi T, Ugajin S, Kaga T. Vinegar intake reduces body weight, body fat mass, and serum 
triglyceride levels in obese Japanese subjects. Bioscience, Biotechnology, and Biochemistry, 73(8): 1837–1843, 2009. 
https://doi.org/10.1271/bbb.90231 
12. Lerman A, Zeiher AM. Endothelial Function: Cardiac Events. Circulation, 111(3): 363–368, 2005. 
https://doi.org/10.1161/01.CIR.0000153339.27064.14 
13. Liatis S, Grammatikou S, Poulia K-A, Perrea D, Makrilakis K, Diakoumopoulou E, Katsilambros N. Vinegar 
reduces postprandial hyperglycaemia in patients with type II diabetes when added to a high, but not to a low, 
glycaemic index meal. European Journal of Clinical Nutrition, 64(7): 727–732, 2010. 
https://doi.org/10.1038/ejcn.2010.89 
14. Navalta JW, Stone WJ, Lyons TS. Ethical Issues Relating to Scientific Discovery in Exercise Science. Int J Exerc 
Sci 12(1): 1-8, 2019. 
Int J Exerc Sci 14(2): 222-229, 2021 
International Journal of Exercise Science                                                          http://www.intjexersci.com 
229 
15. Ostman E, Granfeldt Y, Persson, L Björck, I. Vinegar supplementation lowers glucose and insulin responses and 
increases satiety after a bread meal in healthy subjects. European Journal of Clinical Nutrition, 59(9): 983–988, 2005. 
https://doi.org/10.1038/sj.ejcn.1602197 
16. Peronnet F, Massicotte D. Table of nonprotein respiratory quotient: an update. Can J Sport Sci. 16(1): 23–9, 1991. 
17. Petsiou EI, Mitrou PI, Raptis SA, Dimitriadis GD. Effect and mechanisms of action of vinegar on glucose 
metabolism, lipid profile, and body weight. Nutrition Reviews, 72(10): 651–661, 2014. 
18. Sakakibara S, Murakami R, Takahashi M, Fushimi T, Murohara T, Kishi M, Kaga T. Vinegar intake enhances 
flow-mediated vasodilatation via upregulation of endothelial nitric oxide synthase activity. Bioscience, 
Biotechnology, and Biochemistry, 74(5): 1055–1061, 2010. https://doi.org/10.1271/bbb.90953 
19. Shephard RJ. PAR-Q, Canadian Home Fitness Test and Exercise Screening Alternatives. Sports Medicine, 5(3): 
185–195, 1988. https://doi.org/10.2165/00007256-198805030-00005 
20. Weir JB deV. New methods for calculating metabolic rate with special reference to protein metabolism. The 
Journal of Physiology, 109(1–2), 1–9, 1949. 
21. Yamashita H, Fujisawa K, Ito E, Idei, S, Kawaguchi, N, Kimoto, M, Tsuji, H (2007). Improvement of obesity and 
glucose tolerance by acetate in Type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Bioscience, 
Biotechnology, and Biochemistry, 71(5), 1236–1243. https://doi.org/10.1271/bbb.60668 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
